HCA Healthcare, Inc.
Bear Case (25th pct.)
37.3% vs price
Base Case (Median)
65.6% vs price
Bull Case (75th pct.)
78.3% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-494.35 | -222.1% | High (40%) |
| PE Comparable | $664.74 | 64.1% | Medium (25%) |
| Growth Trajectory DCF | $1040.23 | 156.9% | Medium (20%) |
| EV/EBITDA | $676.30 | 67.0% | Medium (20%) |
| EV/FCF | $519.87 | 28.4% | Medium (20%) |
| Earnings Power Value | $737.26 | 82.0% | Medium (50%) |
Based on 6 out of 8 methods, HCA appears undervalued at the current price of $404.98. The base case fair value of $670.52 implies 65.6% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.